CDEK
← All organizations

Imperial Chemical Industries

For profitContributed to NME

Also known as: Imperial Brands PLC

Phase 1Phase 2Phase 3Phase 4

Highest phase reached

Phase 1

First clinical trial

Dec 31, 2013

First marketed drug

Jan 1, 1926

First NDA

Jun 1, 1954

Last known activity

Jul 7, 2023

Acquired by AkzoNobel on Jan 1, 2008

Timeline

1890s

  1. Jun 1, 1896

    brilliant blue g— NDA Organization

1920s

  1. Jan 1, 1926

    Imperial Chemical Industries— Founded

  2. Jan 1, 1926

    British Dyestuffs Corporation— Acquired

  3. Jan 1, 1926

    Brunner Mond— Acquired

  4. Jan 1, 1926

    Nobel Explosives— Acquired

  5. Jan 1, 1926

    United Alkali Company— Acquired

1970s

  1. Jan 1, 1972

    Atlas Chemical Industries— Acquired

2000s

  1. Jan 24, 2002

    metformin— Marketing Organization

  2. Jan 1, 2008

    AkzoNobel— Acquired By

Drugs by trial phase (2 distinct, 6 trials)

Phase 1 (1 own, 0 via acquisition)

Other trials (1 own, 0 via acquisition)

Indications

Approved for

Marketed drugs (3)

Subsidiaries (5 direct, 6 total across the full acquisition tree)

Recent trials (6)

Details

Founded
London, GB Jan 1, 1926
First NDA
Jun 1, 1954
Last known activity
Jul 7, 2023

Designations held

  • Orphan drug
  • Priority review